KLK1 Antibodies

Santa Cruz Biotechnology provides a broad selection of KLK1 monoclonal antibodies for investigating kallikrein-related peptidase 1 protein. KLK1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Kallikrein-related peptidase 1 plays essential roles in blood pressure regulation, inflammation, and tissue remodeling. KLK1 dysregulation has been linked to various diseases, highlighting its importance as a target for therapeutic intervention and biomarker discovery. Research focusing on KLK1 continues to reveal new insights into cardiovascular health and cancer biology. Scientists worldwide rely on high-quality tools to advance their understanding of kallikrein-related peptidase 1 function and regulation. Ongoing studies of KLK1 are uncovering promising therapeutic applications in multiple disease areas. Extensive research protocols combined with reliable reagents help ensure reproducible experimental results. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge about kallikrein-related peptidase 1.